
Randall E. Chin
Examiner (ID: 12787, Phone: (571)272-1270 , Office: P/3723 )
| Most Active Art Unit | 3723 |
| Art Unit(s) | 3723, 1744, 3405, 2402, 2899 |
| Total Applications | 3278 |
| Issued Applications | 2426 |
| Pending Applications | 139 |
| Abandoned Applications | 726 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19875795
[patent_doc_number] => 20250108052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => IMMUNOPHILIN BINDING AGENTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/957502
[patent_app_country] => US
[patent_app_date] => 2024-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 129980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18957502
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/957502 | IMMUNOPHILIN BINDING AGENTS AND USES THEREOF | Nov 21, 2024 | Pending |
Array
(
[id] => 19098134
[patent_doc_number] => 20240117362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => LIPID-PEGYLATED COMPOUNDS, PREPARATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/451013
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18451013
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/451013 | Lipid-pegylated compounds, preparations and uses thereof | Aug 15, 2023 | Issued |
Array
(
[id] => 18955244
[patent_doc_number] => 20240043571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => BIO-BASED STARCH MIXED ESTER BIODEGRADABLE AND/OR COMPOSTABLE COMPOSITIONS AND METHODS FOR MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/227663
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18227663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/227663 | BIO-BASED STARCH MIXED ESTER BIODEGRADABLE AND/OR COMPOSTABLE COMPOSITIONS AND METHODS FOR MAKING THE SAME | Jul 27, 2023 | Pending |
Array
(
[id] => 18737785
[patent_doc_number] => 20230346679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => WATER DISPERSABLE FILM-FORMING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/305840
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305840
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/305840 | WATER DISPERSABLE FILM-FORMING COMPOSITION | Apr 23, 2023 | Pending |
Array
(
[id] => 19809590
[patent_doc_number] => 12240961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Cellulose acetate resin composition
[patent_app_type] => utility
[patent_app_number] => 18/106507
[patent_app_country] => US
[patent_app_date] => 2023-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8129
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18106507
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/106507 | Cellulose acetate resin composition | Feb 6, 2023 | Issued |
Array
(
[id] => 18537478
[patent_doc_number] => 20230242571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => SILICON CONTAINING MODIFIED NUCLEOTIDE ANALOGS
[patent_app_type] => utility
[patent_app_number] => 18/104690
[patent_app_country] => US
[patent_app_date] => 2023-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104690
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/104690 | SILICON CONTAINING MODIFIED NUCLEOTIDE ANALOGS | Jan 31, 2023 | Pending |
Array
(
[id] => 19921706
[patent_doc_number] => 12295965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Methods of treating sepsis using anti-sepsis lipid a (ASLA) based therapeutics
[patent_app_type] => utility
[patent_app_number] => 18/086290
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 42
[patent_no_of_words] => 24524
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086290
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086290 | Methods of treating sepsis using anti-sepsis lipid a (ASLA) based therapeutics | Dec 20, 2022 | Issued |
Array
(
[id] => 18466863
[patent_doc_number] => 20230201143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/086313
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086313
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086313 | METHODS OF TREATMENT | Dec 20, 2022 | Abandoned |
Array
(
[id] => 19730092
[patent_doc_number] => 12208078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Tiglien-3-one derivatives
[patent_app_type] => utility
[patent_app_number] => 18/055778
[patent_app_country] => US
[patent_app_date] => 2022-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 16715
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18055778
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/055778 | Tiglien-3-one derivatives | Nov 14, 2022 | Issued |
Array
(
[id] => 19448906
[patent_doc_number] => 20240309036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Phenol Compound-Linked Pentagalloyl Glucose Derivatives and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/007505
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007505
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007505 | Phenol Compound-Linked Pentagalloyl Glucose Derivatives and Uses Thereof | Oct 23, 2022 | Pending |
Array
(
[id] => 18511339
[patent_doc_number] => 20230227480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => POLYHYDROXYLATED CYCLOPENTANE DERIVATIVES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/960202
[patent_app_country] => US
[patent_app_date] => 2022-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960202 | POLYHYDROXYLATED CYCLOPENTANE DERIVATIVES AND METHODS OF USE | Oct 4, 2022 | Pending |
Array
(
[id] => 18223455
[patent_doc_number] => 20230062449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS FOR PURIFICATION OF MESSENGER RNA
[patent_app_type] => utility
[patent_app_number] => 17/871121
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871121 | METHODS FOR PURIFICATION OF MESSENGER RNA | Jul 21, 2022 | Pending |
Array
(
[id] => 18158572
[patent_doc_number] => 20230025164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => ANTIMICROBIAL WITH MODIFIED-CHITOSAN FUNCTIONALIZATION VIA DOPAMINE LINKAGE
[patent_app_type] => utility
[patent_app_number] => 17/869064
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869064 | Antimicrobial with modified-chitosan functionalization via dopamine linkage | Jul 19, 2022 | Issued |
Array
(
[id] => 18077760
[patent_doc_number] => 20220403372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHOD FOR EXTRACTION OF CELL-FREE DNA
[patent_app_type] => utility
[patent_app_number] => 17/838767
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838767 | METHOD FOR EXTRACTION OF CELL-FREE DNA | Jun 12, 2022 | Abandoned |
Array
(
[id] => 18340316
[patent_doc_number] => 20230132265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/835363
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 751
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835363 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND THE USE THEREOF | Jun 7, 2022 | Pending |
Array
(
[id] => 18091305
[patent_doc_number] => 20220409646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => MALTOSYL-ISOMALTO-OLIGOSACCHARIDES REDUCE SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/835727
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835727 | MALTOSYL-ISOMALTO-OLIGOSACCHARIDES REDUCE SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE | Jun 7, 2022 | Abandoned |
Array
(
[id] => 18142182
[patent_doc_number] => 20230016026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => MIXTURE OF BRANCHED SECONDARY ALCOHOL ETHOXYLATES FOR REMOVAL OF ENDOTOXINS IN ANION EXCHANGE CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/833675
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833675 | Mixture of branched secondary alcohol ethoxylates for removal of endotoxins in anion exchange chromatography | Jun 5, 2022 | Issued |
Array
(
[id] => 18064435
[patent_doc_number] => 20220395522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => Methods of Use of Glucosamine for Increasing Nitrogen Retention
[patent_app_type] => utility
[patent_app_number] => 17/832165
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/832165 | Methods of Use of Glucosamine for Increasing Nitrogen Retention | Jun 2, 2022 | Pending |
Array
(
[id] => 17880314
[patent_doc_number] => 20220295791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => METHODS FOR VIRAL INACTIVATION BY ENVIRONMENTALLY COMPATIBLE DETERGENTS
[patent_app_type] => utility
[patent_app_number] => 17/830726
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830726 | METHODS FOR VIRAL INACTIVATION BY ENVIRONMENTALLY COMPATIBLE DETERGENTS | Jun 1, 2022 | Pending |
Array
(
[id] => 19717331
[patent_doc_number] => 12202854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Process for the production of DATH and intermediates thereof
[patent_app_type] => utility
[patent_app_number] => 17/745471
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10088
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745471
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745471 | Process for the production of DATH and intermediates thereof | May 15, 2022 | Issued |